Genetic Polymorphism
13
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE
The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.
Effects of Exercise Training and Genetic Factors in Hypertensive Patients with Obstructive Sleep Apnea Sleep
Genetic Polymorphism and Retinopathy of Prematurity: Correlation of Clinical Presentations and Severity
Multicentric Cohort of Melanoma Patients in Ile de France Area
Satraplatin and Prednisone to Treat Prostate Cancer
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
Effects of Heme Arginate in Healthy Male Subjects
Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects
CYP19 Genetic Polymorphism & Aromatase Inhibitor(AI)
Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia
Association Study of Gene Polymorphisms With Cardiac Performance